Oncology EQA Programmes

Our Oncology EQA programmes support laboratories in assessing, comparing, and improving performance across a range of oncology-related tests used in the diagnosis, monitoring, and management of cancer.

These schemes strengthen quality assurance in areas such as tumour marker analysis, monoclonal protein investigation, and prostate cancer testing, helping laboratories maintain analytical accuracy, meet accreditation standards, and ensure confidence in results that inform clinical decision-making.

For those seeking oncology resources or educational insight into oncology testing, these programmes cover many of the core assays used to support cancer diagnosis, disease monitoring, recurrence detection, and clinical trials.

Alongside our EQA services, we further educational support through the Digital Academy, including commentaries, webinars, and technical presentations that reinforce continual professional development in oncology testing.

All programmes below are administered by UK NEQAS for Immunology, Immunochemistry & Allergy (UK NEQAS IIA) and are available to national and international participants.

Programmes in this category

• Monoclonal Proteins (SER/019)
  Supports the diagnosis of monoclonal gammopathies in serum and urine, including assessment of monoclonal component identification and quantitation, free light chains, and related parameters.
  
  
• Total PSA (SER/020) & Free PSA (SER/030)
  
  
• Tumour Markers
  Covers a range of tumour markers used in the diagnosis and management of malignant disease, including ovarian, breast, gastrointestinal, lung, and neuroendocrine markers:
• • Ovarian Markers (CA125) (SER/021)
  • Gut Markers (CA199) (SER/022)
  • Breast Markers (CA153) (SER/023)
  • Lung Markers (NSE) (SER/024)
  • Chromogranin A (SER/049)

• Ultrasensitive PSA (SER/058)
  Supports laboratories measuring ultrasensitive PSA as a marker of recurrence in post-radical prostatectomy patients.

Supporting UK proficiency testing and quality assurance in oncology

Accurate and consistent oncology testing is critical for patient diagnosis, treatment decisions, and clinical trials. Our Oncology EQA programmes are designed to support UK proficiency testing in oncology by enabling laboratories to benchmark performance against peers, identify sources of variability, and apply best practice consistently.

These schemes also contribute to wider UK quality assurance in oncology, supporting laboratories in meeting regulatory expectations and maintaining high analytical standards across routine and specialist testing.

Oncology education and quality improvement

Oncology educational resources are available through the Digital Academy to support understanding of analytical performance, interpretation challenges, and emerging practice in oncology testing. By combining EQA participation with targeted education, laboratories can translate assessment outcomes into meaningful and sustained quality improvement.

Register Today

Don’t hesitate to contact us for further information, and register here to participate today.